Zhejiang Hisoar Pharmaceutical Co., Ltd. elected Tao Hong as non-independent director; and Yu Yongping, Qian Jianmin and Liang Chao as independent directors at the Extraordinary General Meeting held on November 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.36 CNY | +0.79% | -1.24% | -11.54% |
28/04 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
18/04 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.54% | 139.32Cr | |
+29.90% | 68TCr | |
+30.35% | 59TCr | |
-3.68% | 36TCr | |
+17.67% | 33TCr | |
+3.27% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+7.59% | 17TCr |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Zhejiang Hisoar Pharmaceutical Co., Ltd. Elects Tao Hong as Non-Independent Director; and Yu Yongping, Qian Jianmin and Liang Chao as Independent Directors